Alternations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications

Author： Liu Caigang   Zhang Hao   Shuang Chen   Lu Yang   Jin Feng   Xu Huimian   Lu Ping  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.27, Iss.3, 2010-09, pp. : 747-752

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma

By                  

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 2924-2934

Spandidos Publications

Access to resources Recommend Favorite

p53 Protein Expression, Cell Proliferation and Steroid Hormone Receptors in Ductal and Lobular In Situ Carcinomas of the Breast

By Rudas M.   Neumayer R.   Gnant M.F.X.   Mittelbock M.   Jakesz R.   Reiner A.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 39-44

Elsevier

Access to resources Recommend Favorite

p53 Protein Expression, Cell Proliferation and Steroid Hormone Receptors in Ductal and Lobular In Situ Carcinomas of the Breast Rudas

By Schmitt F.C.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1903-1903

Elsevier

Access to resources Recommend Favorite

p53 protein expression in ductal carcinoma in situ (DCIS) of the breast

By Rajan P.B.  

Breast Cancer Research and Treatment, Vol. 42, Iss. 3, 1997-02 ,pp. : 283-290

Springer Publishing Company

Access to resources Recommend Favorite

A functional polymorphism of TGFBR2 is associated with risk of breast cancer with ER+, PR+, ER+PR+ and HER2- expression in women

By                

Oncology Letters, Vol. 2, Iss. 4, 2011-01 ,pp. : 653-658

Spandidos Publications

Access to resources Recommend Favorite